Skip to main content


Fig. 3 | Journal of Translational Medicine

Fig. 3

From: HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

Fig. 3

Timecourse of the HALT & REVERSE project. A baseline blood sample (red bar) is obtained from all patients 1 day prior to the procedure. In the pulmonary vein isolation—and cardiac surgery group, the study procedure (black bar epicardial or endocardial mapping procedure) is performed during the elective therapeutic intervention (yellow bar) and post-procedural continuous rhythm monitoring afterwards (green bars). The blue bars indicate long term follow-up (>3 months) including a visit to the outpatient clinic with electrocardiography, blood samples and 24-h Holter recordings when indicated

Back to article page